Peripheral insulin resistance and impaired insulin signaling contribute to abnormal glucose metabolism in preterm baboons

Endocrinology (United States)

Volumn 156, Issue 3, 2015, Pages 813-823

  Blanco, Cynthia L ^a   McGill Vargas, Lisa L ^a   Gastaldelli, Amalia ^a,c   Seidner, Steven R ^a   McCurnin, Donald C ^a   Leland, Michelle M ^a   Anzueto, Diana G ^a   Johnson, Marney C ^a   Liang, Hanyu ^a,b   DeFronzo, Ralph A ^a,b   Musi, Nicolas ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Texas Diabetes Institute   (United States)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCAGON; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR BETA; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P85; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BABOON; BEGINNING OF HUMAN LIFE; BIRTH; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; FATTY ACID BLOOD LEVEL; FEMALE; GESTATIONAL AGE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NEWBORN; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE CLAMP TECHNIQUE; METABOLISM; PHYSIOLOGY; PREGNANCY; VERTEBROBASILAR INSUFFICIENCY;

ANIMALS; BLOOD GLUCOSE; FEMALE; GENE EXPRESSION REGULATION; GLUCAGON; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; INSULIN RESISTANCE; MUSCLE, SKELETAL; PAPIO; PREGNANCY; PREMATURE BIRTH; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; VERTEBROBASILAR INSUFFICIENCY;

EID: 84923902084     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1757     Document Type: Article

References (46)

1. Martin JA, Hamilton BE, Ventura SJ, Osterman MJK, Matthews TJ. Births: final data for 2011. Centers for Disease Control and Prevention, National Center for Health Statistics. Natl Vital Stat Rep. 2013;62(1):1-69, 72.
2. Whincup PH, Kaye SJ, Owen CG, et al. Birth weight and risk of type 2 diabetes. JAMA. 2008;300:2886-2897.
3. Hovi P, Andersson S, Eriksson JG, et al. Glucose regulation in young adults with very low birth weight. N Engl J Med. 2007;356:2053-2063.
4. Hofman PL, Regan F, Cutfield WS. Prematurity - another example of perinatal metabolic programming? Horm Res. 2006;66:33-39.
5. Rotteveel J, van Weissenbruch MM, Delemarre-Van de Waal HA. Decreased insulin sensitivity in small for gestational age males treated with GH and preterm untreated males: a study in young adults. Eur J Endocrinol. 2008;158:899-904.
6. Bacchetta J, Harambat J, Dubourg L, et al. Both extrauterine and intrauterine growth restriction impair renal function in children born very preterm. Kidney Int. 2009;76:445-452.
7. Hack M. Young adult outcomes of very low-birth-weight children. Semin Fetal Neonatal Med. 2006;11:127-137.
8. Blanco CL, Baillargeon JG, Morrison RL, Gong AK. Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities. J Perinatol. 2006;26:737-741.
9. Hey E. Hyperglycaemia and the very preterm baby. Semin Fetal Neonatal Med. 2005;10:377-387.
10. Garg R, Agthe AG, Donohue PK, Lehmann CU. Hyperglycemia and retinopathy of prematurity in very low birth weight infants. J Perinatol. 2003;23:186-194.
11. Hall NJ, Peters M, Eaton S, Pierro A. Hyperglycemia is associated with increased morbidity and mortality rates in neonates with necrotizing enterocolitis. J Pediatr Surg. 2004;39:898-901.
12. Alexandrou G, Skiold B, Karlen J, et al. Early hyperglycemia is a risk factor for death and white matter reduction in preterm infants. Pediatrics. 2010;125:e584-e591.
13. Liechty EA. The resistant premie: documenting the prevalence of hyperglycemia in the extremely low birth weight infant. J Pediatr. 2010;157:699-700.
14. Hewson M, Nawadra V, Oliver J, Odgers C, Plummer J, Simmer K. Insulin infusions in the neonatal unit: delivery variation due to adsorption. J Pediatr Child Health. 2000;36:216-220.
15. Goldman SL, Hirata T. Attenuated response to insulin in very low birthweight infants. Pediatr Res. 1980;14:50-53.
16. Ng SM, May JE, Emmerson AJ. Continuous insulin infusion in hyperglycaemic extremely low-birth-weight neonates. Biol Neonate. 2005;87:269-272.
17. Mitanchez-Mokhtari D, Lahlou N, Kieffer F, Magny JF, Roger M, Voyer M. Both relative insulin resistance and defective islet β-cell processing of proinsulin are responsible for transient hyperglycemia in extremely preterm infants. Pediatrics. 2004;113:537-541.
18. Magnusson A, Powell T, Jansson T. Glucose metabolism in the human preterm and term placenta of IUGR fetuses. Placenta. 2004; 25:337-346.
19. Wallace JM, Milne JS, Aitken RP, Hay WW. Sensitivity to metabolic signals in late-gestation growth-restricted fetuses from rapidly growing adolescent sheep. Am J Physiol Endocrinol Metab. 2007; 293:E1233-E1241.
20. Jefferson AC. Regulation of Muscle glucose update in vivo. In: Mandarino LR, Bonadonna O, McGuinness A, Halseth, Wasserman D, eds. The Handbook of Physiology. Oxford, United Kingdom: The Oxford University Press; 2001:803-848.
21. Del Prato S, Leonetti F, Simonson DC, Sheehan P, Matsuda M, DeFronzo RA. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia. 1994;37:1025-1035.
22. Tantiwong P, Shanmugasundaram K, Monroy A, et al. NF-κB activity in muscle from obese and type 2 diabetic subjects under basal and exercise-stimulated conditions. Am J Physiol Endocrinol Metab. 2010;299:E794-E801.
23. Shepherd PR, Kahn BB. Glucose transporters and insulin action - implications for insulin resistance and diabetes mellitus. N Engl J Med. 1999;341:248-257.
24. Anderson MS, Flowers-Ziegler J, Das UG, Hay WW, Devaskar SU. Glucose transporter protein responses to selective hyperglycemia or hyperinsulinemia in fetal sheep. AmJ Physiol Regulatory Integrative Comp Physiol. 2001;281:R1545-R1552.
25. He J, Thamotharan M, Devaskar SU. Insulin-induced translocation of facilitative glucose transporters in fetal/neonatal rat skeletal muscle. Am J Physiol Regulatory Integrative Comp Physiol. 2003;284: R1138-R1146.
26. Blanco CL, Liang H, Joya-Galeana J, DeFronzo RA, McCurnin D, Musi N. The ontogeny of insulin signaling in the preterm baboon model. Endocrinology. 2010;151:1990-1997.
27. Blanco CL, McGill-Vargas LL, McCurnin D, Quinn AR. Hyperglycemia increases the risk of death in extremely preterm baboons. Pediatr Res. 2013;73:337-343.
28. Chavez AO, Lopez-Alvarenga JC, Tejero ME, et al. Physiological and molecular determinants of insulin action in the baboon. Diabetes. 2008;57:899-908.
29. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab. 1979;237:E214-E223.
30. Hulman SE, Kliegman RM. Assessment of insulin resistance in newborn beagles with the euglycemic hyperinsulinemic clamp1. Pediatr Res. 1989;25:219-223.
31. Kelly BA, Lewandowski AJ, Worton SA, et al. Antenatal glucocorticoid exposure and long-term alterations in aortic function and glucose metabolism. Pediatrics. 2012;129:e1282-e1290.
32. Li S, Zhang M, Tian H, Liu Z, Yin X, Xi B. Preterm birth and risk of type 1 and type 2 diabetes: systematic review and meta-analysis. Obes Rev. 2014;15(10):804-811.
33. Wang G, Divall S, Radovick S. Preterm birth and random plasma insulin levels at birth and in early childhood. JAMA. 2014;311:587-596.
34. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J BiolChem. 2001;276:38349-38352.
35. Bae SS, Cho H, Mu J, Birnbaum MJ. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/Protein Kinase B. J Biol Chem. 2003;278:49530-49536.
36. Pessin JE, Bell GI. Mammalian facilitative glucose transporter family: structure and molecular regulation. Annu Rev Physiol. 1992; 54:911-930.
37. Marshall BA, Ren JM, Johnson DW, et al. Germline manipulation of glucose homeostasis via alteration of glucose transporter levels in skeletal muscle. J Biol Chem. 199;268:18442-18445.
38. Koopmans SJ, Ohman L, Haywood JR, Mandarino LJ, DeFronzo RA. Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats. Diabetes. 1997;46:1572-1578.
39. Ervin MG, Seidner SR, Leland MM, Ikegami M, Jobe AH. Direct fetal glucocorticoid treatment alters postnatal adaptation in premature newborn baboons. Am J Physiol Regulatory Integrative Comp Physiol. 1998;274:R1169-R1176.
40. Quinn AR, Blanco C, Perego C, et al. The ontogeny of the endocrine pancreas in the fetal/newborn baboon. J Endocrinol. 2012;214: 289-299.
41. Maianu L, Keller SR, Garvey WTJ. Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking. Clin Endocrinol Metab. 2001;86(11):5450-5456.
42. Algenstaedt P, Rosenblatt N, Kolb I, Krützelmann A, et al. A new model of primary human adipocytes reveals reduced early insulin signalling in type 2 diabetes. Horm Metab Res. 2004;36(8):531-537.
43. Berends LM, Fernandez-Twinn DS, Martin-Gronert MS, Cripps RL, Ozanne SE. Catch-up growth following intra-uterine growth-restriction programmes an insulin-resistant phenotype in adipose tissue. Int J Obes (Lond). 2013;37(8):1051-1057.
44. Massaeli H, Hurtado C, Austria JA, Pierce GN. Oxidized low-density lipoprotein induces cytoskeletal disorganization in smooth muscle cells. Am J Physiol Heart Circ Physiol. 1999;277:H2017-H2025.
45. Lewandowski AJ, Lazdam M, Davis E, et al. Short-term exposure to exogenous lipids in premature infants and long-term changes in aortic and cardiac function. Arterioscler Thromb Vasc Biol. 2011; 31:2125-2135.
46. TODAY Study Group. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013;36:1735-1741.